From the printing of simple prosthetics to pre-surgical aids, 3D printing continues to prove its usefulness in medicine. Yet, medicine has only accessed the tip of the usefulness of 3D printing.

The exploration of the full range of 3D printing’s usefulness has moved as step forward with the announcement that Stratasys Ltd. and the New York-based Jacobs Institute will work together to create a Center of Excellence (COE) to advance the use of 3D printing in medical applications.

The new COE will leverage Stratasys’ 3D printing technology to develop and test new medical devices using 3D printed prototypes and models and enrich clinical education and training activities for a variety of audiences. The Center will also serve as a referral source for hospitals and medical research organizations that are considering implementing 3D printing labs.

Stratasys is supporting the COE by providing 3D printing systems featuring a combination of vibrant colors and diverse material properties including different levels of opacity and rigidity. Stratasys will collaborate with the Jacobs Institute on technical and clinical case studies that include 3D printed applications, and also provide financial support for vital research projects.

“This announcement with the Jacobs Institute is an important milestone, marking the first time we are formally partnering with a medical organization to explore the exciting opportunities of 3D printing and healthcare,” said Scott Rader, General Manager, Medical Solutions, Stratasys.